Harvard Apparatus Regenerative Technology to Present at 2nd Annual Regen Med Investor Day in New York City

[Business Wire] – Harvard Apparatus Regenerative Technology, Inc. , a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will present at the 2nd Annual Regen Med Investor Day in New York C more

View todays social media effects on HART

View the latest stocks trending across Twitter. Click to view dashboard

See who Harvard is hiring next, click here to view